Stille AB (SE:STIL)
:STIL
Want to see SE:STIL full AI Analyst Report?
Top Page
Stille AB
(STIL)
Select Model
Select Model
Rating:70Outperform
Price Target:
kr284.00
▲(52.28% Upside)
Action:ReiteratedDate:04/25/26
The score is driven primarily by solid profitability and a very conservative balance sheet, offset by weak cash conversion versus earnings. Technicals are supportive but overbought conditions raise near-term risk, while valuation (P/E ~23.5 with no dividend yield provided) is a mild headwind.
Positive Factors
Strong margins
Sustained gross (~51%) and EBIT (~15%) margins indicate durable pricing power and operating efficiency in surgical devices. High structural margins support reinvestment in R&D, service infrastructure and cushion profits during volume swings, aiding multi-quarter resilience.
Negative Factors
Weak cash conversion
Operating cash flow coverage (~0.31) and FCF at ~54% of net income show earnings do not reliably convert to cash. Persistent working-capital swings or investment timing can constrain liquidity and limit the durability of reported profits for funding growth or distributions.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong margins
Sustained gross (~51%) and EBIT (~15%) margins indicate durable pricing power and operating efficiency in surgical devices. High structural margins support reinvestment in R&D, service infrastructure and cushion profits during volume swings, aiding multi-quarter resilience.
Read all positive factors
Stille AB (STIL) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr2.13B
Dividend YieldN/A
Average Volume (3M)6.57K
Price to Earnings (P/E)23.5
Beta (1Y)0.07
Revenue Growth10.34%
EPS Growth2.50%
CountrySE
Employees162
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)2.31
Shares Outstanding8,985,447
10 Day Avg. Volume9,615
30 Day Avg. Volume6,571
Financial Highlights & Ratios
PEG Ratio-7.86
Price to Book (P/B)2.48
Price to Sales (P/S)3.10
P/FCF Ratio112.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.7
Revenue Forecast (FY)kr689.95M
Stille AB Business Overview & Revenue Model
Company Description
Stille AB develops, manufactures, and sells surgical instruments in Sweden and internationally. It offers artery forceps and ligature clamps; bone cutters and rongeurs; clamps, curettes, raspatories, elevators, forceps, and micro instruments; need...
How the Company Makes Money
Stille makes money mainly by selling medical-technology products and related services to healthcare providers. Its core revenue streams are (1) sales of surgical instruments used in surgical procedures, and (2) sales of surgical tables used in ope...
Stille AB Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
84
Very Positive
Cash Flow
62
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 617.41M | 567.63M | 569.95M | 294.89M | 246.35M | 187.09M |
| Gross Profit | 309.82M | 287.97M | 295.64M | 132.17M | 111.57M | 83.46M |
| EBITDA | 102.36M | 72.69M | 118.97M | 56.04M | 44.78M | 28.89M |
| Net Income | 61.99M | 55.70M | 58.21M | 26.65M | 27.32M | 16.10M |
Balance Sheet | ||||||
| Total Assets | 1.10B | 1.05B | 1.00B | 804.89M | 342.55M | 308.85M |
| Cash, Cash Equivalents and Short-Term Investments | 138.22M | 118.66M | 158.49M | 241.45M | 36.68M | 27.80M |
| Total Debt | 0.00 | 123.26M | 63.09M | 62.94M | 70.77M | 81.48M |
| Total Liabilities | 355.76M | 345.54M | 301.70M | 172.64M | 152.74M | 160.75M |
| Stockholders Equity | 742.97M | 708.71M | 699.40M | 632.25M | 189.81M | 148.10M |
Cash Flow | ||||||
| Free Cash Flow | 32.10M | 15.59M | 59.24M | 24.37M | 23.89M | -11.74M |
| Operating Cash Flow | 49.88M | 36.05M | 73.53M | 37.28M | 31.94M | 7.28M |
| Investing Cash Flow | -105.34M | -104.30M | -330.31M | -12.90M | -8.04M | -51.90M |
| Financing Cash Flow | 41.95M | 36.16M | 171.40M | 178.99M | -18.54M | 33.22M |
Stille AB Technical Analysis
Positive
186.50
Price Trends
192.75
Positive
188.21
Positive
199.90
Positive
Market Momentum
8.37
Positive
60.00
Neutral
29.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:STIL, the sentiment is Positive. The current price of 186.5 is below the 20-day moving average (MA) of 212.60, below the 50-day MA of 192.75, and below the 200-day MA of 199.90, indicating a bullish trend. The MACD of 8.37 indicates Positive momentum. The RSI at 60.00 is Neutral, neither overbought nor oversold. The STOCH value of 29.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:STIL.
Stille AB Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | kr2.13B | 23.52 | ― | ― | 10.34% | 2.50% | |
56 Neutral | kr1.18B | -74.03 | -4.20% | ― | 23.85% | -135.36% | |
55 Neutral | kr840.80M | 103.06 | 6.93% | ― | -5.76% | -81.59% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | kr1.03B | -61.68 | -4.42% | ― | 4.66% | 27.83% | |
48 Neutral | kr744.41M | -7.33 | -36.55% | ― | 48.53% | 17.86% | |
47 Neutral | kr453.01M | -24.57 | ― | ― | 34.51% | 5.70% |
* Healthcare Sector Average
SE:STIL
Stille AB
237.50
55.50
30.49%
SE:PAX
Paxman AB
50.60
-25.80
-33.77%
SE:SEZI
Senzime AB
4.74
-0.09
-1.97%
SE:CRAD.B
C-Rad AB Class B
24.90
-5.10
-17.00%
SE:SEDANA
Sedana Medical AB
10.32
0.10
0.98%
SE:OSSD
OssDsign AB
4.10
-9.21
-69.21%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.